The 27 references in paper A. Shevchenko V., V. Konenkov I., O. Golovanova V., A. Blagodatskikh E., E. Garbukov Yu., M. Stakheeva N., А. Шевченко В., В. Коненков И., О. Голованова В., А. Благодатских Е., Е. Гарбуков Ю., М. Стахеева Н. (2014) “ПОЛИМОРФИЗМ ГЕНА VEGFA (С-2578A, C+936T) У ПАЦИЕНТОК С РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ // VEGFA GENE POLYMORPHISM (С-2578A, C+936T) IN PATIENTS WITH BREAST CANCER” / spz:neicon:mimmun:y:2012:i:2:p:87-94

1
Abe A., Sato K., Habuchi T., Wang L., Li Z., Tsuchiya N., Ohyama C., Satoh S., Ogawa O., Kato T.. Single nucleotide polymorphisms in the 3` untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinom // Tohoku J. Exp Med. – 2002. – Vol. 198. – P. 181-190.
(check this in PDF content)
2
Aldridge S.E., Lennard T.W.J., Williams J.R., Birch M.A. Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bo // British Journal of Cancer. – 2005. – Vol. 92. – P. 1531-1537.
(check this in PDF content)
3
Awata T., Inoue K., Kurihara S., Tomoko O., Masaki W., Kouichi I., Ikuo I., Shigehiro K. A common polymorphism in the 5`-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabete // Diabetes. – 2002. – Vol. 51. – P. 1635-1639.
(check this in PDF content)
4
Banyasz I., Szabó S., Bokodi G., Vannay ó., Vósórhelyi B., Szabó A., Tulassay T., Rigó J. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsi // Molecular Human Reproduction. – 2006. – Vol. 12 (4). – P. 233-236.
(check this in PDF content)
5
Bland J.M., Altman D.G. Education and debate. The odds rati // BMJ. – 2000. – Vol. 320. – P. 1468 .
(check this in PDF content)
6
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases // Nature. – 2000. – Vol. 407. – P. 249-257.
(check this in PDF content)
7
Carron S.L., Edwards S., Evans P.R., Gibbs R., Dearnaley D.P., Dowe A., Southgate C., Easton D.F., Eeles R.A., Howell W.M. Influence of cytokine gene polymorphisms on the development of prostate cance // Cancer Res. – 2002. – Vol. 62. – P. 3369-3372.
(check this in PDF content)
8
Clar H., Krippl P., Renner W., Langsenlehner T., Clar V., Windhager R., Langsenlehn U. Association of polymorphisms of angiogenesis genes with breast cance // Breast Cancer Rec Treat. – 2009. – Vol. 113. – P. 197-198.
(check this in PDF content)
9
Ferrara N., Gerber H.P. The role of vascular endothelial growth factor in angiogenesis // Acta Haematol. – 2001. – Vol. 106. – P. 148-156.
(check this in PDF content)
10
Ferrara N., Gerber H.P., Le Couter J.. The biology of VEGF and its receptors // Nat Med. – 2003. – Vol. 9. – P. 669-676.
(check this in PDF content)
11
Foekens J.A., Peters H.A., Grebenchtchikov N., Look M.P., Meijer-van Gelder M.E., GeurtsMoespot A., van der Kwast T.H., Sweep C.G.J., Klijn J.G.M. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cance // Cancer Res. – 2001. – Vol. 61. – P. 5407-5414.
(check this in PDF content)
12
Hadaschik D., Hinterkeuser K., Oldak M., Pfister H.J., Smola-Hess S. The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiatio // J. Virol. – 2003. – Vol. 77. – P. 5253-5265.
(check this in PDF content)
13
Howell W.M., Bateman A.C., Turner S.J., Collins A., Theaker J.M. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanom // Genes Immun. – 2002. – Vol. 3. – P. 229-232.
(check this in PDF content)
14
Jacobs E. J., Feigelson H. S., Bain E.B., Brady K.A., Rodriguez C., Stevens V.L., Patel A.V., Thun M.J., Calle E.E. Рolymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohor // Breast Cancer Research. – 2006. – Vol. 8(22). – http:// breast-cancer-research.com/content/8/2/R22
(check this in PDF content)
15
Jin Q., Hemminki K., Enquist K., Lenner P., Grzybowska E., Klaes R., Henriksson R., Chen B., Pamula J., Pekala W., Zientek H., RogozinskaSzczepka J., Utracka-Hutka B., Hallmans G., Fórsti A. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis // Clin Cancer Res. – 2005. – Vol. 11. – P. 3647-3653.
(check this in PDF content)
16
Kim J.K., Oh D., Kwak S.Y., Han J.H., Chung Y.S., Kim N.K. Genetic Polymorphism of Vascular Endothelial Growth Factor (VEGF C936T) in the Korean Populati // Korean J. Biol Sci. – 2003. – Vol. 7. – P. 261-264.
(check this in PDF content)
17
Krippl P., Langsenlehner U., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., Paulweber B., Haas J., Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer ris // Int J. Cancer. – 2003. – Vol. 106. – P. 468-471.
(check this in PDF content)
18
Krippl P., Langsenlehner U., Samonigg H., Renner W., Koppel H. Vascular Endothelial Growth Factor in Predicting Outcome in Breast Cance // Clin Cancer Res. – 2004. – Vol. 10. – P. 8752-8753.
(check this in PDF content)
19
Lynn K.D., Roland C.L., Brekken R.A. VEGF and Pleiotrophin Modulate the Immune Profile of Breast Canc // Cancers. – 2010. – Vol. 2. – P. 970-988.
(check this in PDF content)
20
Mazumder B., Seshadri V., Fox P.L. Translational control by the 3`-UTR: the ends specify the means // Trends Biochem Sci. – 2003. – Vol. 28. – P. 91-98.
(check this in PDF content)
21
Mohammadi M., Ollier W.E., Hutchinson I.V. A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cell // Hum Immunol. – 2003. – Vol. 64. – P. 125.
(check this in PDF content)
22
Nobuhiko K., Qiuyin C., Wanqing W., XiaoOu S., Fan J., Yu-Tang G., Wei Z. Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Wome // Cancer Epidemiol Biomarkers Prev. – 2006. – Vol. 15. – P. 1148-1152.
(check this in PDF content)
23
Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma level // J. Vasc Res. – 2000. – Vol. 37. – P. 443-448.
(check this in PDF content)
24
Shahbazi M., Fryer A.A., Pravica V., Brogan I.J., Ramsay H.M., Hutchinson I.V., Harden P.N. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejectio // J. Am. Soc. Nephrol. – 2002. – Vol. 13. – P. 260-264.
(check this in PDF content)
25
Smith K.C., Bateman A.C., Fussell H.M., Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosi // Eur. J. Immunogenet. – 2004. – Vol. 31. – P. 167-173.
(check this in PDF content)
26
Vincenti V., Cassano C., Rocchi M., Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 // Circulation. – 1996. – Vol. 93. – P. 1493-1495.
(check this in PDF content)
27
Watson C.J., Webb N.J., Bottomley M.J., Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene:correlation with variation in VEGF protein productio // Cytokine . – 2000. – Vol. 12. – P. 1232-
(check this in PDF content)